The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.
Innovation Orbit 2026 is FI Group by EPSA’s international guide to grants, R&D tax credits and public incentives for businesses planning R&D, CAPEX, digital transformation or decarbonisation projects.
The second in our series of skills webinars for the BIA Finance and Tax Community explored the key considerations for biotech companies expanding overseas, with insights and reflections from advisors and company leaders with firsthand international experience.
